S
LRMR icon

SignatureFD’s Larimar Therapeutics LRMR Stock Holding History

SignatureFD’s Portfolio LRMR Stock Details LRMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.6K Buy
+853
New +$3.39K ﹤0.01% 3079
2026
Q1 		– Sell
-105
Closed -$400 – 3548
2025
Q4 		$400 Sell
105
-578
-85% -$2.25K ﹤0.01% 3255
2025
Q3 		$2.21K Buy
+683
New +$2.56K ﹤0.01% 2923
2025
Q1 		– Sell
-8
Closed -$31 – 3388
2024
Q4 		$31 Sell
8
-316
-98% -$2.09K ﹤0.01% 3270
2024
Q3 		$2.12K Buy
324
+239
+281% +$1.92K ﹤0.01% 2822
2024
Q2 		$616 Buy
+85
New +$651 ﹤0.01% 2964

Other funds holding LRMR

DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DCM
Defilade Capital Management Emeryville, California $747M AUM
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return

SignatureFD's LRMR Position: Q2 2026 in Review

SignatureFD opened a new position in Larimar Therapeutics (LRMR) in Q2 2026: 853 shares worth $2.6K. The stake represents ﹤0.01% of the portfolio and ranks #3079 among its holdings. This is a return to the name: SignatureFD previously reported a position in LRMR as recently as Q4 2025.

SignatureFD first reported a position in LRMR in Q2 2024 and has held it in 6 quarters since. 163 funds tracked by Wall St. Rank hold LRMR as of Q2 2026.

  • SignatureFD held 853 shares of Larimar Therapeutics worth $2.6K as of Q2 2026.
  • Larimar Therapeutics was a new SignatureFD position in Q2 2026.
  • Larimar Therapeutics made up ﹤0.01% of SignatureFD's portfolio in Q2 2026, its #3079 holding.
  • SignatureFD first reported a position in Larimar Therapeutics in Q2 2024 and has held it in 6 quarters since.
  • 163 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q2 2026.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.